GLP-1/GLP-1R Signaling Regulates Ovarian PCOS-Associated Granulosa Cells Proliferation and Antiapoptosis by Modification of Forkhead Box Protein O1 Phosphorylation Sites
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
As the major cause of female anovulatory infertility, polycystic ovary syndrome (PCOS) affects a great proportion of women at childbearing age. Although glucagon-like peptide 1 receptor agonists (GLP-IRAs) show therapeutic effects for PCOS, its target and underlying mechanism remains elusive. In the present study, we identified that, both in vivo and in vitro , GLP-1 functioned as the regulator of proliferation and antiapoptosis of MGCs of follicle in PCOS mouse ovary. Furthermore, forkhead box protein O1 (FoxO1) plays an important role in the courses. Regarding the importance of granulosa cells (GCs) in oocyte development and function, the results from the current study could provide a more detailed illustration on the already known beneficial effects of GLP-1RAs on PCOS and support the future efforts to develop more efficient GLP-1RAs for PCOS treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In PCOS, FOXO1 promotes follicle atresia and granulosa cell apoptosis by activation of pro-apoptotic proteins such as p27Kip1 and Bim, thereby contributing to the cystic changes in the ovaries13,14.”
From Efficacy and safety of GLP-1 receptor agonists on weight management and metabolic parameters in PCOS women: a meta-analysis of randomized controlled trials (2025) · cites this paper as [14]
Experimental — accuracy not yet measuredIn the citing paper
“In this part of the study, the authors demonstrated the GLP-1R was expressed in mural granulosa cells (MGCs), and its expression was decreased in the PCOS model.”
From Liraglutide and polycystic ovary syndrome: is it only a matter of body weight? (2023) · cites this paper as [42]
In the citing paper
“The administration of liraglutide significantly attenuated PCOS-associated ovarian MGCs apoptosis in a concentration-dependent manner, and these effects were associated to modifications of the phosphorylation sites of forkhead box protein O1 (FoxO1), a negative regulator of cell survival.”
From Liraglutide and polycystic ovary syndrome: is it only a matter of body weight? (2023) · cites this paper as [42]
In the citing paper
“Compared to the placebo group, in the liraglutide group the body weight reduced significantly, and up to 40% mice recovered regular estrous cycles, but testosterone levels were only slightly decreased and the reduction in fasting insulin was not statistically significant.”
From Liraglutide and polycystic ovary syndrome: is it only a matter of body weight? (2023) · cites this paper as [42]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138 · cited 1×
“-e manifestations of PCOS generally include oligomenorrhea or amenorrhea, abnormal folliculogenesis, chronic anovulation, hyperandrogenemia, and infertility [2].”
BackgroundAzziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132
Dynamic FoxO transcription factors
Huang, H., & Tindall, D. J. (2007) · Journal of Cell Science · doi:10.1242/jcs.001222 · Cited by 1,113
Dijkers, P. F., Medema, R. H., Pals, C., Banerji, L., Thomas, N. S. B., Lam, E. W.-F., Burgering, B. M. T., Raaijmakers, J. A. M., Lammers, J.-W. J., Koenderman, L., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.24.9138-9148.2000 · Cited by 617
FoxO proteins in insulin action and metabolism
Barthel, A., Schmoll, D., & Unterman, T. G. (2005) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2005.03.010 · Cited by 604 · cited 1×
“Given that phosphorylation modification is an important regulator of FoxO1 transcriptional activity [24].”
BackgroundFollicle dynamics and anovulation in polycystic ovary syndrome
Franks, S., Stark, J., & Hardy, K. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn015 · Cited by 581 · cited 1×
“Also, GCs apoptosis-induced follicular atresia is the main cause of failure in dominant follicle selection [27].”
BackgroundGlucagon-like peptide 1 in health and disease
Andersen, A., Lund, A., Knop, F. K., & Vilsbøll, T. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0016-2 · Cited by 543
Oocyte competence in women with polycystic ovary syndrome
Palomba, S., Daolio, J., & La Sala, G. B. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.11.008 · Cited by 294 · cited 2×
“PCOS is the most frequent cause of female anovulatory infertility [3].”
BackgroundRecent updates on GLP-1 agonists: Current advancements & challenges
Sharma, D., Verma, S., Vaidya, S., Kalia, K., & Tiwari, V. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.088 · Cited by 265 · cited 1×
“GLP1 is an incretin hormone that exhibits several pharmacological actions such as neuroprotection, increased cognitive function, cardioprotection, decreased hypertension, suppression of acid secretion, and protection from inflammation [29].”
BackgroundThe SUMO protease SENP5 is required to maintain mitochondrial morphology and function
Zunino, R., Schauss, A., Rippstein, P., Andrade-Navarro, M., & McBride, H. M. (2007) · Journal of Cell Science · doi:10.1242/jcs.03418 · Cited by 264 · cited 1×
“Its main function is to inhibit cell proliferation and promote cell apoptosis and cycle arrest [34].”
BackgroundRichards, J. S., Sharma, S., Falender, A. E., & Lo, Y. (2002) · Molecular Endocrinology · doi:10.1210/me.16.3.580 · Cited by 206 · cited 1×
“Most importantly, High level of FoxO1 are expressed in follicular GCs in different develop stages and peak in atresia follicles [35, 36].”
BackgroundSalamun, V., Jensterle, M., Janez, A., & Vrtacnik Bokal, E. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0175 · Cited by 204 · cited 1×
“Moreover, preconception intervention with low-dose liraglutide added to metformin increased the in vitro fertilization pregnancy rate in infertile obese women with PCOS [10].”
BackgroundJensterle Sever, M., Kocjan, T., Pfeifer, M., Kravos, N. A., & Janez, A. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-0797 · Cited by 175
Liu, X., Zhang, Y., Zheng, S., Lin, R., Xie, Y., Chen, H., Zheng, Y., Liu, E., Chen, L., Yan, J., et al. (2017) · Clinical Endocrinology · doi:10.1111/cen.13454 · Cited by 148 · cited 1×
“GLP-1RAs treatment, it was also observed that the level of androgens was modestly decreased and the menstrual frequency was increased [8, 11, 12].”
BackgroundNylander, M., Frøssing, S., Clausen, H. V., Kistorp, C., Faber, J., & Skouby, S. O. (2017) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2017.03.023 · Cited by 139 · cited 1×
“In addition to the effects of GLP-1/GLP-1R axis on metabolism, GLP-1R agonists (GLP-1RAs, such as liraglutide) also improved the markers of ovarian function (bleeding pattern; levels of AMH (Anti-Müllerian hormone)), sex hormones, gonadotropins, and ovarian morphology in overweight women with PCOS [9].”
BackgroundThe role of glucagon-like peptide-1 in reproduction: from physiology to therapeutic perspective
Jensterle, M., Janez, A., Fliers, E., DeVries, J. H., Vrtacnik-Bokal, E., & Siegelaar, S. E. (2019) · Human Reproduction Update · doi:10.1093/humupd/dmz019 · Cited by 128 · cited 1×
“Some scholars think that GLP-1 might be one of the most important modulating signals connecting the reproductive and metabolic system and there is mostly stimulating role of GLP-1 and its mimetics in mammalian reproduction that goes beyond mere weight reduction [13].”
BackgroundAspects of Ovarian Follicle Development throughout Life
Macklon, N., & Fauser, B. C. J. M. (1999) · Hormone Research in Paediatrics · doi:10.1159/000023456 · Cited by 113 · cited 1×
“-e secretion regulates the growth, differentiation, and maturation of follicular cells and oocytes, thereby regulating the development of follicles [26].”
BackgroundHigh-Fat Diet Induces Significant Metabolic Disorders in a Mouse Model of Polycystic Ovary Syndrome1
Lai, H., Jia, X., Yu, Q., Zhang, C., Qiao, J., Guan, Y., & Kang, J. (2014) · Biology of Reproduction · doi:10.1095/biolreprod.114.120063 · Cited by 112
FOXO1/3 Depletion in Granulosa Cells Alters Follicle Growth, Death and Regulation of Pituitary FSH
Liu, Z., Castrillon, D. H., Zhou, W., & Richards, J. S. (2013) · Molecular Endocrinology · doi:10.1210/me.2012-1296 · Cited by 97 · cited 1×
“FoxO1, a member of the class O in Forkhead transcription factor (Fox) family, regulated by PI3K/Akt pathway, is involved in many pathological and physiological processes including cell proliferation, apoptosis, autophagy, metabolism, inflammatory response, and so forth [15].”
BackgroundBakhshalizadeh, S., Amidi, F., Alleyassin, A., Soleimani, M., Shirazi, R., & Nashtaei, M. S. (2017) · Systems Biology in Reproductive Medicine · doi:10.1080/19396368.2017.1296046 · Cited by 82 · cited 1×
“Immunofluorescence staining was used to detect the expression and localization of FSHR (folliclestimulating hormone receptor), a specific marker of GCs, to identify the isolated cells as GCs [23].”
MethodGLP-1 receptor agonists in the treatment of polycystic ovary syndrome
Lamos, E. M., Malek, R., & Davis, S. N. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1292125 · Cited by 71 · cited 2×
“Considering its reported effects on insulin, the GLP-1/GLP-1R axis is a promising drug target for metabolic diseases [7, 8].”
BackgroundFoxO proteins: regulation and molecular targets in liver cancer.
Carbajo‐Pescador, S., Mauriz, J., García-palomo, A., & González-Gallego, J. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666131228205703 · Cited by 69 · cited 1×
“After phosphorylation of ser319, it can generate nuclear signal to promote the transfer out of nucleus [41].”
BackgroundGebremedhn, S., Salilew-Wondim, D., Hoelker, M., Rings, F., Neuhoff, C., Tholen, E., Schellander, K., & Tesfaye, D. (2016) · Biology of Reproduction · doi:10.1095/biolreprod.115.137539 · Cited by 66
Molecular signatures of ovarian diseases: Insights from network medicine perspective
Kori, M., Göv, E., & Arğa, K. Y. (2016) · Systems Biology in Reproductive Medicine · doi:10.1080/19396368.2016.1197982 · Cited by 65 · cited 1×
“-e complex pathogenesis of PCOS includes abnormal expression of apoptosis correlated genes, MAPK signaling pathway, and cell cycle associated molecules [4].”
BackgroundHerndon, M. K., Law, N. C., Donaubauer, E. M., Kyriss, B., & Hunzicker-Dunn, M. E. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.06.020 · Cited by 64 · cited 1×
“FoxO1 gene is expressed in GCs of follicles at different developmental stages, and FoxO1 expression is the highest in GCs of atresia follicles, mainly in the nucleus of GCs [16, 17].”
BackgroundShi, F., & LaPolt, P. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1790195 · Cited by 63 · cited 1×
“Most importantly, High level of FoxO1 are expressed in follicular GCs in different develop stages and peak in atresia follicles [35, 36].”
BackgroundZhao, L., Li, A. Q., Zhou, T. F., Zhang, M. Q., & Qin, X. M. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00151.2014 · Cited by 61
Bao, Y., Jiang, L., Chen, H., Zou, J., Liu, Z., & Shi, Y. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430199 · Cited by 60
Honnma, H., Endo, T., Henmi, H., Nagasawa, K., Baba, T., Yamazaki, K., Kitajima, Y., Hayashi, T., Manase, K., & Saito, T. (2006) · Apoptosis · doi:10.1007/s10495-006-9148-2 · Cited by 60 · cited 1×
“-ese results, all together, suggested that GCs apoptosis played an essential role in the mediation of follicular atresia in PCOS [28].”
BackgroundExendin-4 inhibits growth and augments apoptosis of ovarian cancer cells
He, W., Yu, S., Wang, L., He, M., Cao, X., Li, Y., & Xiao, H. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.07.032 · Cited by 58 · cited 1×
“In contrast, few studies have been conducted focusing on GLP-1R expression in the ovary with an exception that reported the GLP-1R is expressed in human ovarian tumor cells [14].”
BackgroundProtective Action of Liraglutide in Beta Cells Under Lipotoxic Stress Via PI3K/Akt/FoxO1 Pathway
Shao, S., Nie, M., Chen, C., Chen, X., Zhang, M., Yuan, G., Yu, X., & Yang, Y. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24763 · Cited by 55 · cited 2×
“Interaction between GLP-1 and FoxO1 has been reported in pancreatic B cells [19, 20].”
BackgroundHou, Y., Ernst, S. A., Heidenreich, K., & Williams, J. A. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00293.2015 · Cited by 47
Tzotzas, T., Karras, S., & Katsiki, N. (2017) · Current Vascular Pharmacology · doi:10.2174/1570161114666161221115324 · Cited by 39 · cited 1×
“Considering its reported effects on insulin, the GLP-1/GLP-1R axis is a promising drug target for metabolic diseases [7, 8].”
BackgroundExpression of forkhead transcription factors in human granulosa cells
Pisarska, M., Kuo, F.-T., Tang, D., Zarrini, P., Khan, S., & Ketefian, A. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.04.054 · Cited by 35 · cited 1×
“FoxO1 gene is expressed in GCs of follicles at different developmental stages, and FoxO1 expression is the highest in GCs of atresia follicles, mainly in the nucleus of GCs [16, 17].”
BackgroundHoang, V., Bi, J., MohanKumar, S. M. J., & Vyas, A. K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126119 · Cited by 33 · cited 1×
“2mg/kg) [22] for 21 consecutive days and the rest (n� 30) also received saline injections twice daily.”
MethodLan, Z., Krause, M. S., Redding, S. D., Li, X., Wu, G. Z., Zhou, H., BOHLER, H. C. L., Ko, C. J., Cooney, A. J., Zhou, J., et al. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.01.043 · Cited by 33 · cited 1×
“It played an important role in promoting follicular atresia and apoptosis of GCs [18, 37].”
BackgroundOncogenic RAS-induced CK1α drives nuclear FOXO proteolysis
Zhang, F., Virshup, D. M., & Cheong, J. K. (2017) · Oncogene · doi:10.1038/onc.2017.334 · Cited by 26 · cited 1×
“-e phosphorylation of three highly conserved phosphorylation sites -r24, Ser256, and Ser319 by PI3K/Akt is the main activity regulation mode [39].”
BackgroundKim, Y.-K., Park, J.-H., Park, S.-H., Lim, B., Baek, W., Suh, S., Lim, J.-G., Ryu, G., & Song, D. (2010) · Cellular Physiology and Biochemistry · doi:10.1159/000276555 · Cited by 25
Connolly, A., Leblanc, S., & Baillargeon, J. (2018) · International Journal of Endocrinology · doi:10.1155/2018/4315413 · Cited by 23 · cited 1×
“It is accompanied by a series of metabolic disorders that may disrupt ovarian function, such as dyslipidemia, type 2 diabetes, insulin resistance, and compensatory hyperinsulinemia [25].”
BackgroundKinase inhibitors of HER2/AKT pathway induce ERK phosphorylation via a FOXO-dependent feedback loop.
Matkar, S. S., An, C., & Hua, X. (2017) · PubMed · Cited by 22
Protection of pancreatic β-cells against glucotoxicity by short-term treatment with GLP-1
Park, S.-H., Park, J., Shim, H. M., Na, A., Bae, K.-C., Lim, J.-G., & Song, D. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.02.139 · Cited by 20 · cited 1×
“Interaction between GLP-1 and FoxO1 has been reported in pancreatic B cells [19, 20].”
BackgroundChuffa, L. G. D. A., Lupi, L. A., & Lima, A. F. D. M. (2016) · Tissue & Cell · doi:10.1016/j.tice.2015.12.003 · Cited by 16 · cited 1×
“More specifically, the proliferation and apoptosis of GCs are the fundamental causes of follicular development and atresia [5].”
Background
Research works printed but not linked: 2
- 10.1210/mend.16.3.0806 · doi:10.1210/mend.16.3.0806 · Paper page
- 2017, American Journal of Cancer Research, 7, 1476
Cited by
GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
Zhao, X., Wang, M., Wen, Z., Lu, Z., Cui, L., Fu, C., Xue, H., Liu, Y., & Zhang, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.721135 · Cited by 463
Zhou, L., Qu, H., Yang, L., & Shou, L. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01500-5 · Cited by 66
“Sun et al. reported the contribution of GLP-1 to the regulation of ovarian granulosa cells proliferation and antiapoptosis, thereby promoting oocyte maturation in PCOS rats [53].”
BackgroundAbdalla, M. A., Deshmukh, H., Atkin, S., & Sathyapalan, T. (2021) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018821989238 · Cited by 60
Lin, S., Deng, Y., Huang, J., Li, M., Sooranna, S. R., Qin, M., & Tan, B. (2025) · Scientific Reports · doi:10.1038/s41598-025-99622-4 · Cited by 35
Chauvin, S. (2025) · Biomolecules · doi:10.3390/biom15070923 · Cited by 39
“In PCOS mouse models, GLP-1RAs have partially restored estrous cyclicity and improved MGC proliferation, partly through the inactivation of the pro-apoptotic FOXO1 [179].”
Metadata
- Authors
- Sun, Z., Li, P., Wang, X., Lai, S., Qiu, H., Chen, Z., Hu, S., Yao, J., & Shen, J.
- Affiliations
- Third Affiliated Hospital of Southern Medical University (CN)
- Southern Medical University (CN)
- Corresponding author
- Shen, Jie
- Venue
- International Journal of Endocrinology
- Publisher
- Wiley
- Published
- 2020-06-19
- Volume
- 2020
- Pages
- 1-10
- ISSN
- 1687-8337 (ISSN-L)
- 1687-8345
- PMC
- PMC7321515
- OpenAlex
- W3036323776
- Cited by
- 37
- References
- 42
- Citations by year
- 2026: 6 · 2025: 13 · 2024: 5 · 2023: 7 · 2022: 3 · 2021: 3
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- International Journal of Endocrinology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Natural Science Foundation of Guangdong Province (2018A030313997, A2019186, 2017-Z04-35)
- Guangdong Medical Science and Technology Research Fund Project (2018A030313997, A2019186, 2017-Z04-35)
- Science and Technology Program of Panyu District (2018A030313997, A2019186, 2017-Z04-35)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Keywords
- polycystic ovary syndrome, glucagon-like peptide-1, GLP-1 receptor agonists, granulosa cells, FOXO1 phosphorylation, cell proliferation, apoptosis, oogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.